Dividends Calendar Earnings Calendar
CARA

CARA | Cara Therapeutics

Cara Therapeutics
Category: Biotechnology company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Stamford, Connecticut, United States

Trade prices

  • Volume:
  • Market Cap: 597.62M
  • Prev closed: 21.75
  • Open: 22.16
  • High: 23.89
  • Low: 22.05
  • 52 week low: 11.94
  • 52 week high: 23.89
  • Dividends:No Dividends

Next ER: August 9, 2021 



Top Stories (CARA)

    Company Profile

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs).

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 5, 2021- / -0.63- / 2.83M
    May 10, 2021-0.47 / -0.611.94M / 2.83M
    February 25, 20211.59 / 0.3643112.09M / 5.98MBeat!
    November 9, 2020-0.35 / -0.59719.27M / 4.73MBeat!
    August 10, 2020-0.54 / -0.675.63M / 5.01MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jul 26, 2021 12.53 12.08
    12.75
    11.86
    131.47K 4.94%
    Jul 23, 2021 11.94 12.57
    12.57
    11.89
    669.76K -5.31%
    Jul 22, 2021 12.61 12.93
    12.97
    12.53
    394.24K -2.7%
    Jul 21, 2021 12.96 12.77
    13.04
    12.62
    374.10K 1.41%
    Jul 20, 2021 12.78 13.13
    13.27
    12.58
    496.89K -1.84%
    Jul 19, 2021 13.02 12.86
    13.04
    12.67
    317.59K 0.23%
    Jul 16, 2021 12.99 13.04
    13.13
    12.73
    263.44K 0.39%
    Jul 15, 2021 12.94 13.00
    13.05
    12.67
    400.20K -1.3%
    Jul 14, 2021 13.11 13.42
    13.53
    13.05
    321.44K -2.53%
    Jul 13, 2021 13.45 13.83
    13.88
    13.31
    378.62K -3.45%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2004
    • Employees:80

    News

    News for (CARA)

    This company doesn't provide a dividend.


    Talk about Cara Therapeutics below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 9, 2021 (Same day)

    tsn meli apd cf enr acm zyne iii cara elan rcl doyu 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    LinkedIn

    Peers / Similar stocks 

    jnj xlv pfe 

    Other stocks 

    csco pg hpq aap mik hrl dnow lrcx pfe mdt omc gsat 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.